Drug Type Small molecule drug |
Synonyms KNP 2002, KNP2002 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Warts | Phase 2 | Japan | 12 Jun 2023 |
Phase 2 | 159 | zajcyopjjr(peeqpupdaq) = We recognize that the results of this study could show the safety of the drug 2 and demonstrate its efficacy against verruca vulgaris at least in certain subsets of patients. kdppithfph (vpavjxhilb ) | Positive | 08 Aug 2025 | |||
placebo |





